[DOI] [PubMed] [Google Scholar] [86].Hofmann GA, Gradl G, Schulz M, Haidinger G, Tanew A, Weber B, The frequency of photosensitizing drug dispensings in Austria and Germany: a correlation with their photosensitizing potential based on published literature, J
This is why many people feel like their supplements aren't "doing anything." The Liposomal Difference To solve this, we use liposomal delivery
Qi X, Xiao S, Chen X, Ali I, Gou J, Wang D, Zhu B, Zhu W, Shang R, Han M (2022) Biochar-based microbial agent reduces U and Cd accumulation in vegetables and improves rhizosphere microecology
Lipids Health Dis 9:35
Disclosures: Steven Flamm: Nothing to Disclose, Mitchell Shiffman: Bio89: Grant/Research Support, CymaBay: Advisor, CymaBay: Grant/Research Support, Durect: Grant/Research Support, Galectin: Grant/Research Support, Genentech: Grant/Research Support, Genentech: Speaking and Teaching, Gilead: Grant/Research Support, Gilead: Advisor, Gilead: Speaking and Teaching, HepQuant: Grant/Research Support, HepQuant: Advisor, Hamni: Grant/Research Support, High Tide: Grant/Research Support, Interept: Grant/Research Support, Interecept: Speaking and Teaching, Intercept: Advisor, Intra-Sana: Advisor, Intra-Sana: Speaking and Teaching, Ipsen: Advisor, Ipsen: Grant/Research Support, Ipsen: Speaking and Teaching, Madrigal: Grant/Research Support, Madrigal: Speaking and Teaching, Mirum: Grant/Research Support, Pliant: Grant/Research Support, Salix: Grant/Research Support, Salix: Advisor, Viking: Grant/Research Support, Aparna Goel: Nothing to Disclose, Allison Kwong: Nothing to Disclose, Lance Stein: Abbvie: Speaking and Teaching, Gilead: Speaking and Teaching, GSK: Consultant, Intercept: Speaking and Teaching, Intercept: Consultant, Madrigal: Speaking and Teaching, Ipsen: Speaking and Teaching, Ashwini Mehta: Nothing to Disclose, Christophe Moreno: Echosens: Consultant, Surrozen: Consultant, Gilead: Consultant, Julius Clinical: Consultant, Alexandre LOUVET: Glaxo-Smith-Kline: Consultant, AbbVie: Speaking and Teaching, Gilead: Speaking and Teaching, Ipsen: Consultant, Astra-Zeneca: Speaking and Teaching, Sanjaya Satapathy: Gilead Sciences: Grant/Research Support, Durect Pharma: Grant/Research Support, Fibronostics: Grant/Research Support, Novartis: Grant/Research Support, Zydus Pharma: Grant/Research Support, Boehringer Ingelheim: Grant/Research Support, Intercept Pharma: Grant/Research Support, Alexander Kuo: Nothing to Disclose, Daniel Ganger: WCG: Consultant, Costica Aloman: Nothing to Disclose, Amanda Nicoll: Nothing to Disclose, Simone Strasser: Chiesi: Advisor, Roche Diagnostics: Advisor, Roche Therapeutics: Advisor, Norgine: Speaking and Teaching, Abbott Diagnostics: Advisor, CSL Behring: Advisor, Novo Nordisk: Advisor, Astra Zeneca: Advisor, Sirtex: Speaking and Teaching, Eisai: Speaking and Teaching, Mack Mitchell: GlaxoSmithKline: Advisor, Amygdala Neuroscience: Consultant, Parvus Therapeutics: Advisor, HepaTX: Advisor, Durect: Grant/Research Support, Srinivasan Dasarathy: Nothing to Disclose, Edmund Tse: Nothing to Disclose, Mark Thursz: Durect: Consultant, GSK: Consultant, Resolution Tx: Consultant, Intercept: Consultant, Galecto: Consultant, Durect: Consultant, Craig McClain: Novo Nordisk: Grant/Research Support, Intercept Pharmaceuticals: Grant/Research Support, Altimmune: Grant/Research Support, Target Pharma Solutions: Grant/Research Support, NIH: Grant/Research Support, VAMC: Grant/Research Support, William Krebs: DURECT, Incorporated: Independent Contractor, RISE Therapeutics: Independent Contractor, Deborah Scott: Nothing to Disclose, Christina Blevins: Nothing to Disclose, Julie Fergus: Nothing to Disclose, Jim Brown: Durect Corporation: Employee, Norman Sussman: Durect Corporation: Employee, WeiQi Lin: Nothing to Disclose, David Ellis: DURECT Corp.: Employee 1573 SUSTAINING A-KINASE ANCHORING PROTEIN-12 EXPRESSION DURING ALCOHOL EXPOSURE MAINTAINS PKA SIGNALING AND REGULATES STEATOSIS Chandana Thimme Gowda 1 MALLIKARJUNA SIRAGANAHALLI ESHWARAIAH 1 Nirmala Mavila 2 Jiaohong Wang 1 Maria Lauda Tomasi 1 Komal Ramani 2 , 1 Cedars Sinai Medical Centre, 2 Cedars-Sinai Medical Center Background: Alcohol- associated liver disease (ALD) is associated with disrupted lipogenic signaling and fat accumulation in the liver
Angiogenesis and vasculogenic mimicry are inhibited by 8-Br-cAMP through activation of the cAMP/PKA pathway in colorectal cancer
